Chronic glucose-dependent insulinotropic polypeptide receptor (GIPR) agonism desensitizes adipocyte GIPR activity mimicking functional GIPR antagonism
Both agonism and antagonism of the glucose-dependent insulinotropic polypeptide receptor (GIPR) lead to weight loss in combination with glucagon-like peptide-1 receptor agonists in preclinical models. Here the authors show that this may be explained by desensitization of GIPR activity by chronic GIP...
Guardado en:
Autores principales: | Elizabeth A. Killion, Michelle Chen, James R. Falsey, Glenn Sivits, Todd Hager, Larissa Atangan, Joan Helmering, Jae Lee, Hongyan Li, Bin Wu, Yuan Cheng, Murielle M. Véniant, David J. Lloyd |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/35bda07550384ea78b2522ff1a815550 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Free fatty acids, glicentin and glucose-dependent insulinotropic polypeptide as potential major determinants of fasting substrate oxidation
por: Julia Hummel, et al.
Publicado: (2021) -
The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect
por: Enrique Z. Fisman, et al.
Publicado: (2021) -
Adipocyte Atrophy Mimicking Signet Ring Cell Carcinoma of the Gallbladder
por: Benjamin van Haeringen, et al.
Publicado: (2021) -
Foxp1 controls brown/beige adipocyte differentiation and thermogenesis through regulating β3-AR desensitization
por: Pei Liu, et al.
Publicado: (2019) -
Nanocomplexes of an insulinotropic drug: optimization, microparticle formation, and antidiabetic activity in rats
por: Elmowafy E, et al.
Publicado: (2014)